{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T17:44:46Z","timestamp":1777052686242,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.intimp.2004.01.022","type":"journal-article","created":{"date-parts":[[2004,2,26]],"date-time":"2004-02-26T13:25:52Z","timestamp":1077801952000},"page":"349-353","source":"Crossref","is-referenced-by-count":43,"title":["Cetirizine and allopurinol as novel weapons against cellular autoimmune disorders"],"prefix":"10.1016","volume":"4","author":[{"given":"M.R.","family":"Namazi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2004.01.022_BIB1","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0167-5699(96)80606-2","article-title":"The expanding universe of T-cell subsets: Th1, Th2, and more","volume":"17","author":"Mosman","year":"1996","journal-title":"Immunol. Today"},{"issue":"11","key":"10.1016\/j.intimp.2004.01.022_BIB2","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1096\/fj.03-0002hyp","article-title":"Nicotinamide: a potential addition to the antipsoriatic weaponry","volume":"17","author":"Namazi","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.intimp.2004.01.022_BIB3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00011-003-1175-7","article-title":"Nitric oxide donors as novel additions to anti-alopecia areata armamentarium","volume":"52","author":"Namazi","year":"2003","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.intimp.2004.01.022_BIB4","series-title":"Immunology","first-page":"651","author":"Klein","year":"1999"},{"key":"10.1016\/j.intimp.2004.01.022_BIB5","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1046\/j.1365-2222.1999.00630.x","article-title":"Cetirizine counter-regulates interleukin-8 release from human epithelial cells (A549)","volume":"29","author":"Arnold","year":"1999","journal-title":"Clin. Exp. Allergy"},{"issue":"1","key":"10.1016\/j.intimp.2004.01.022_BIB6","first-page":"1","article-title":"Cetirizine modulates adhesion molecule expression in a double-blind controlled study conducted in psoriatic patients","volume":"25","author":"Peslelli","year":"2003","journal-title":"Int. J. Tissue React."},{"issue":"7","key":"10.1016\/j.intimp.2004.01.022_BIB7","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1365-4362.1995.tb00630.x","article-title":"Pharmacologic modulation by cetirizine of some adhesion molecules expression in psoriatic skin lesions","volume":"34","author":"Caproni","year":"1995","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.intimp.2004.01.022_BIB8","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0091-6749(89)90104-8","article-title":"Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction","volume":"83","author":"Charlesworth","year":"1989","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2004.01.022_BIB9","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1046\/j.1365-2222.1999.00630.x","article-title":"Cetirizine counter-regulates interleukin-8 release from human epithelial cells (A549)","volume":"29","author":"Arnold","year":"1999","journal-title":"Clin. Exp. Allergy"},{"issue":"1","key":"10.1016\/j.intimp.2004.01.022_BIB10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000237310","article-title":"Cetirizine exerts anti-inflammatory effects on human neutrophils","volume":"110","author":"Koller","year":"1996","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.intimp.2004.01.022_BIB11","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1046\/j.1365-2222.1999.00703.x","article-title":"Anti-inflammatory actions of new antihistamines","volume":"29","author":"Editorial","year":"1999","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.intimp.2004.01.022_BIB12","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1124\/pr.54.3.375","article-title":"The therapeutic potential of poly (ADP-ribose) polymerase inhibitors","volume":"54","author":"Virag","year":"2002","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.intimp.2004.01.022_BIB13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF02005756","article-title":"In vitro effect of cetirizine on PGE2 release by rat peritoneal macrophages and human monocytes","volume":"43","author":"Roch-Arveiller","year":"1994","journal-title":"Agents Actions"},{"key":"10.1016\/j.intimp.2004.01.022_BIB14","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0022-4804(89)90019-X","article-title":"Mechanism of immunosuppression following hemorrhage: defective antigen presentation by macrophages","volume":"46","author":"Stephen","year":"1989","journal-title":"J. Surg. Res."},{"issue":"3","key":"10.1016\/j.intimp.2004.01.022_BIB15","first-page":"97","article-title":"Cetirizine reduces in a double blind controlled study the number of tryptase positive mast cells of psoriatic patients","volume":"23","author":"Pestelli","year":"2001","journal-title":"Int. J. Tissue React."},{"key":"10.1016\/j.intimp.2004.01.022_BIB16","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0002-9440(10)64316-7","article-title":"Protease-activated rectptor-2 signalling triggers dendritic cell development","volume":"162","author":"Fields","year":"2003","journal-title":"Am. J. Pathol."},{"issue":"1\u20133","key":"10.1016\/j.intimp.2004.01.022_BIB17","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1159\/000237039","article-title":"Granulocyte recruitment by human mast cell tryptase","volume":"107","author":"Walls","year":"1995","journal-title":"Int. Arch. Allergy Appl. Immunol."},{"key":"10.1016\/j.intimp.2004.01.022_BIB18","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1042\/bst020260s","article-title":"The kininogenase activity of human mast cell tryptase","volume":"20","author":"Walls","year":"1992","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.intimp.2004.01.022_BIB19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0014-2999(97)83033-6","article-title":"Human mast cell trypatase: a stimulus of microvascular leakage and mast cell activation","volume":"328","author":"He","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2004.01.022_BIB20","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.4049\/jimmunol.161.4.1939","volume":"161","author":"Compton","year":"1998","journal-title":"J. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2004.01.022_BIB21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0165-5728(03)00090-0","article-title":"Tryptase activates peripheral blood mononuclear cells causing the synthesis and release of TNF-\u03b1, IL-6, and IL-1\u03b2: possible relevance to multiple sclerosis","volume":"138","author":"Malamud","year":"2003","journal-title":"J. Neuroimmunol."},{"issue":"9","key":"10.1016\/j.intimp.2004.01.022_BIB22","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S1471-4906(03)00233-3","article-title":"Involvement of both \u2018allergic\u2019 and \u2018autoimmune\u2019 mechanisms in EAE, MS and other autoimmune diseases","volume":"24","author":"Pedotti","year":"2003","journal-title":"Trends Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2004.01.022_BIB23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/1044667031000137638","article-title":"Allergic disease and autoimmune effectors pathways","volume":"9","author":"Rottem","year":"2002","journal-title":"Dev. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2004.01.022_BIB24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1254\/jjp.90.7","article-title":"Mast cells as a target of rheumatoid arthritis treatment","volume":"90","author":"Kobayashi","year":"2002","journal-title":"Jpn. J. Pharmacol."},{"issue":"17","key":"10.1016\/j.intimp.2004.01.022_BIB25","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1056\/NEJMcibr023206","article-title":"The mast cell in inflammatory arthritis","volume":"348","author":"Woolley","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.intimp.2004.01.022_BIB26","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/112067210101100307","article-title":"Allopurinol has immunomodulating activity following topical and systemic application in experimental autoimmune uveitis","volume":"11","author":"Grus","year":"2001","journal-title":"Eur. J. Ophthalmol."},{"issue":"5 Suppl.","key":"10.1016\/j.intimp.2004.01.022_BIB27","first-page":"IV351","article-title":"Prolonged cardiac preservation. Evaluation of the University of Wisconsin preservation solution by comparison with the St. Thomas' Hospital cardioplegic solutions in the rat","volume":"82","author":"Ledingham","year":"1990","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.intimp.2004.01.022_BIB28","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/BF00180017","article-title":"The inhibitory effects of allopurinol on the production and cytotoxicity of tumor necrosis factor","volume":"350","author":"Olah","year":"1994","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.intimp.2004.01.022_BIB29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0923-1811(02)00148-2","article-title":"Monocytes-derived multinucleated giant cells and sarcoidosis","volume":"31","author":"Okamoto","year":"2003","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.intimp.2004.01.022_BIB30","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1212\/WNL.59.7.970","article-title":"Cholesterol-lowering statins possess anti-inflammatory activity that might be useful for treating MS","volume":"59","author":"Zamil","year":"2002","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.intimp.2004.01.022_BIB31","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1182\/blood.V87.2.682.bloodjournal872682","article-title":"An ATP-activated channel is involved in mitogenic stimulation of human T lymphocytes","volume":"87","author":"Baricordi","year":"1996","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.intimp.2004.01.022_BIB32","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/0167-5699(95)80045-X","article-title":"The P2Z purinoceptor: an intriguing role in immunity, inflammation, and cell death","volume":"16","author":"Virgilio","year":"1995","journal-title":"Immunol. Today"},{"issue":"4","key":"10.1016\/j.intimp.2004.01.022_BIB33","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1165\/ajrcmb.12.4.7695923","article-title":"Xanthine oxidase-derived oxygen radicals increase lung cytokine expression in mice subjected to hemorrhagic shock","volume":"12","author":"Schwartz","year":"1995","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"2","key":"10.1016\/j.intimp.2004.01.022_BIB34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/112067210301300210","article-title":"Immunological effects of allopurinol in the treatment of experimental autoimmune uveitis (EAU) after onset of the disease","volume":"13","author":"Grus","year":"2003","journal-title":"Eur. J. Ophthalmol."},{"issue":"5","key":"10.1016\/j.intimp.2004.01.022_BIB35","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.4049\/jimmunol.168.5.2483","article-title":"Inflammatory mediators in uveitis: differential induction of cytokines and chemokines in Th1- versus Th2-mediated ocular inflammation","volume":"168","author":"Foxman","year":"2002","journal-title":"J. Immunol."},{"issue":"2\u20133","key":"10.1016\/j.intimp.2004.01.022_BIB36","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/08830180212060","article-title":"Cytokines in immunotherapy of experimental uveitis","volume":"21","author":"DeKozak","year":"2002","journal-title":"Int. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2004.01.022_BIB37","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s004170050270","article-title":"Effects of systemically applied allopurinol and prednisolone on experimental autoimmune uveitis","volume":"237","author":"Augustin","year":"1999","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"3","key":"10.1016\/j.intimp.2004.01.022_BIB38","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1055\/s-2000-10538","article-title":"Immnological effect of systemically administrated allopurinol in experimental autoimmune uveitis","volume":"216","author":"Grus","year":"2000","journal-title":"Klin. Monatsbl. Augenheilkd."},{"issue":"1","key":"10.1016\/j.intimp.2004.01.022_BIB39","first-page":"26","article-title":"Suppression of experimental uveoretinitis with a combination of cyclosporin and allopurinol","volume":"103","author":"Matuura","year":"1999","journal-title":"Nippon Ganka Gakkai Zasshi"},{"issue":"3","key":"10.1016\/j.intimp.2004.01.022_BIB40","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1177\/112067210101100309","article-title":"Differences in the composition of inflammatory cell infiltrate in lens-induced uveitis under therapy with allopurinol or steroids","volume":"11","author":"Sekundo","year":"2001","journal-title":"Eur. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.intimp.2004.01.022_BIB41","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/BF00941740","article-title":"Immunomodulating activity of allopurinol in experimental lens-induced uveitis","volume":"235","author":"Grus","year":"1997","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.intimp.2004.01.022_BIB42","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1046\/j.1365-2230.2002.01149.x","article-title":"Cytokine blocking agents in dermatology","volume":"27","author":"Williams","year":"2002","journal-title":"Clin. Exp. Dermatol."},{"issue":"5","key":"10.1016\/j.intimp.2004.01.022_BIB43","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1096\/fasebj.14.5.691","article-title":"Uric acid, a peroxinitrite scavenger, inhibits CNS inflammation, blood\u2013CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis","volume":"14","author":"Hooper","year":"2000","journal-title":"FASEB J."},{"key":"10.1016\/j.intimp.2004.01.022_BIB44","series-title":"Basic and clinical pharmacology","first-page":"596","article-title":"Nonsteroidal anti-inflammatory drugs, disease-modifying antirheumatic drugs, nonopioid analgesics, and drugs used in gout","author":"Furst","year":"2001"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576904000505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576904000505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:57:33Z","timestamp":1682643453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576904000505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S1567576904000505"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2004.01.022","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}